PuSH - Publikationsserver des Helmholtz Zentrums München

Shafaghat, Z.* ; Radmehr, S.* ; Saharkhiz, S.* ; Khosrozadeh, A.* ; Feiz, K.* ; Alkhathami, A.G.* ; Taheripak, G.* ; Ramezani Farani, M.* ; Rahmati, R.* ; Zarimeidani, F.* ; Bassereh, H. ; Bakhtiyari, S.* ; Alipourfard, I.*

Circular RNA, a molecule with potential chemistry and applications in RNA-based cancer therapeutics: An insight into recent advances.

Top. Curr. Chem. 383:21 (2025)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Non-coding RNAs (ncRNAs) are functional RNA molecules that do not code for proteins. Among these, circular RNAs (circRNAs) represent a recently identified class of endogenous ncRNAs with a pivotal role in gene regulation, alongside short ncRNAs (e.g., microRNAs or miRNAs) and long non-coding RNAs (lncRNAs). CircRNAs are characterized by their single-stranded, covalently closed circular structure, which lacks polyadenylated tails and 5'-3' ends. This unique circular conformation makes them resistant to exonuclease degradation, rendering them more stable than linear RNAs, such as mRNAs in human blood cells, which highlights their potential as biomarkers. Both linear and circular RNAs are derived from pre-mRNA precursors. However, while linear RNAs are produced through conventional splicing, circRNAs are primarily formed through a process known as reverse splicing. CircRNAs can be categorized into five basic types: exon circRNAs, circular intronic RNAs, exon-intron circRNAs, intergenic circRNAs, and fusion circRNAs. These molecules have been shown to significantly influence key hallmarks of cancer, including sustained growth signaling, proliferation, angiogenesis, resistance to apoptosis, unlimited replicative potential, and metastasis. This article will delve into the biogenesis and functions of circRNAs, explore their roles in cancer, and discuss their potential applications as therapeutic options and diagnostic biomarkers.
Impact Factor
Scopus SNIP
Altmetric
8.800
1.458
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Biomarker ; Cancer ; Circrna ; Immunotherapy ; Therapeutic Targets
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 2365-0869
e-ISSN 2364-8961
Quellenangaben Band: 383, Heft: 2, Seiten: , Artikelnummer: 21 Supplement: ,
Verlag Springer
Begutachtungsstatus Peer reviewed
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502200-001
PubMed ID 40343623
Erfassungsdatum 2025-05-11